Puxitatug (INT-016) is a humanised monoclonal antibody targeting VTCN1/B7H4, commonly used as the targeting component of the antibody-drug conjugate (ADC) Puxitatug samrotecan, delivering the drug specifically to cancer cells expressing B7-H4.
Purity:
98.02%
CAS Number:
[2760250-47-1]
Target:
Immunology/Inflammation related|||B7
* VAT and and shipping costs not included. Errors and price changes excepted
